Kingsview Wealth Management, LLC Exact Sciences Corp Transaction History

Kingsview Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$59.06 - $75.72 $142,925 - $183,242	2,420 Added 24.03%	12,491 $924,000
Q3 2023 Nov 07, 2023	BUY	$65.94 - $99.04 $170,125 - $255,523	2,580 Added 34.44%	10,071 $687,000
Q2 2023 Aug 10, 2023	BUY	$62.68 - $95.05 $469,535 - $712,019	7,491 New	7,491 $703,000
Q4 2022 Feb 13, 2023	BUY	$30.35 - $53.15 $156,423 - $273,935	5,154 New	5,154 $255,000
Q2 2022 Aug 16, 2022	SELL	$35.61 - $76.23 $91,695 - $196,292	-2,575 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$72.5 - $100.68 $325,887 - $452,556	-4,495 Reduced 63.58%	2,575 $200,000
Q3 2021 Dec 03, 2021	BUY	$90.24 - $124.05 $126,787 - $174,290	1,405 Added 24.8%	7,070 $675,000
Q2 2021 Aug 17, 2021	BUY	$93.66 - $139.27 $261,311 - $388,563	2,790 Added 97.04%	5,665 $703,000
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $498 - $710	-5 Reduced 0.17%	2,875 $381,000
Q3 2020 Nov 19, 2020	SELL	$72.92 - $102.01 $14,584 - $20,402	-200 Reduced 6.49%	2,880 $294,000
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $171,710 - $285,670	3,080 New	3,080 $268,000

666

152M

4.25M

1.89M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.81B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kingsview Wealth Management, LLC with notifications on news.